Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia
Identifieur interne : 003937 ( PascalFrancis/Checkpoint ); précédent : 003936; suivant : 003938Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia
Auteurs : I. J. Mitchell ; R. Luquin ; S. Boyce ; C. E. Clarke ; R. G. Robertson ; M. A. Sambrook ; A. R. CrossmanSource :
- Movement disorders [ 0885-3185 ] ; 1990.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Cartographie, Singe.
English descriptors
- KwdEn :
Abstract
The 2-deoxyglucose (2-DG) metabolic mapping technique was applied to the animal during the expression of active unilateral dystonia, and regional brain uptake of 2-DG was assessed autoradiographically
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:90-0127385Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia</title><author><name sortKey="Mitchell, I J" sort="Mitchell, I J" uniqKey="Mitchell I" first="I. J." last="Mitchell">I. J. Mitchell</name></author><author><name sortKey="Luquin, R" sort="Luquin, R" uniqKey="Luquin R" first="R." last="Luquin">R. Luquin</name></author><author><name sortKey="Boyce, S" sort="Boyce, S" uniqKey="Boyce S" first="S." last="Boyce">S. Boyce</name></author><author><name sortKey="Clarke, C E" sort="Clarke, C E" uniqKey="Clarke C" first="C. E." last="Clarke">C. E. Clarke</name></author><author><name sortKey="Robertson, R G" sort="Robertson, R G" uniqKey="Robertson R" first="R. G." last="Robertson">R. G. Robertson</name></author><author><name sortKey="Sambrook, M A" sort="Sambrook, M A" uniqKey="Sambrook M" first="M. A." last="Sambrook">M. A. Sambrook</name></author><author><name sortKey="Crossman, A R" sort="Crossman, A R" uniqKey="Crossman A" first="A. R." last="Crossman">A. R. Crossman</name></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">90-0127385</idno><date when="1990">1990</date><idno type="stanalyst">PASCAL 90-0127385 INIST</idno><idno type="RBID">Pascal:90-0127385</idno><idno type="wicri:Area/PascalFrancis/Corpus">003A14</idno><idno type="wicri:Area/PascalFrancis/Curation">002E11</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003937</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia</title><author><name sortKey="Mitchell, I J" sort="Mitchell, I J" uniqKey="Mitchell I" first="I. J." last="Mitchell">I. J. Mitchell</name></author><author><name sortKey="Luquin, R" sort="Luquin, R" uniqKey="Luquin R" first="R." last="Luquin">R. Luquin</name></author><author><name sortKey="Boyce, S" sort="Boyce, S" uniqKey="Boyce S" first="S." last="Boyce">S. Boyce</name></author><author><name sortKey="Clarke, C E" sort="Clarke, C E" uniqKey="Clarke C" first="C. E." last="Clarke">C. E. Clarke</name></author><author><name sortKey="Robertson, R G" sort="Robertson, R G" uniqKey="Robertson R" first="R. G." last="Robertson">R. G. Robertson</name></author><author><name sortKey="Sambrook, M A" sort="Sambrook, M A" uniqKey="Sambrook M" first="M. A." last="Sambrook">M. A. Sambrook</name></author><author><name sortKey="Crossman, A R" sort="Crossman, A R" uniqKey="Crossman A" first="A. R." last="Crossman">A. R. Crossman</name></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="1990">1990</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term><term>Autoradiography</term><term>Brain</term><term>Cartography</term><term>Densitometry</term><term>Dopamine antagonist</term><term>Dystonia</term><term>Experimental disease</term><term>Extrapyramidal syndrome</term><term>Monkey</term><term>Nervous system diseases</term><term>Pathogenesis</term><term>Radionuclide study</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term><term>Extrapyramidal syndrome</term><term>Antagoniste dopamine</term><term>Pathologie expérimentale</term><term>Pathogénie</term><term>Cartographie</term><term>Densitométrie</term><term>Autoradiographie</term><term>Encéphale</term><term>Exploration radioisotopique</term><term>Système nerveux pathologie</term><term>Singe</term><term>Animal</term><term>MPTP</term><term>Glucose(désoxy-2)</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Cartographie</term><term>Singe</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 2-deoxyglucose (2-DG) metabolic mapping technique was applied to the animal during the expression of active unilateral dystonia, and regional brain uptake of 2-DG was assessed autoradiographically</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>5</s2></fA05><fA06><s2>1</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia</s1></fA08><fA11 i1="01" i2="1"><s1>MITCHELL (I. J.)</s1></fA11><fA11 i1="02" i2="1"><s1>LUQUIN (R.)</s1></fA11><fA11 i1="03" i2="1"><s1>BOYCE (S.)</s1></fA11><fA11 i1="04" i2="1"><s1>CLARKE (C. E.)</s1></fA11><fA11 i1="05" i2="1"><s1>ROBERTSON (R. G.)</s1></fA11><fA11 i1="06" i2="1"><s1>SAMBROOK (M. A.)</s1></fA11><fA11 i1="07" i2="1"><s1>CROSSMAN (A. R.)</s1></fA11><fA14 i1="01"><s1>Univ. Manchester, school biological sci., dep. cell structural biology</s1><s2>Manchester M13 9PT</s2><s3>GBR</s3><sZ>A11011000</sZ></fA14><fA20><s1>49-54</s1></fA20><fA21><s1>1990</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>CNRS</s1><s2>20953</s2></fA43><fA44><s0>0000</s0></fA44><fA45><s0>22 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>90-0127385</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>The 2-deoxyglucose (2-DG) metabolic mapping technique was applied to the animal during the expression of active unilateral dystonia, and regional brain uptake of 2-DG was assessed autoradiographically</s0></fC01><fC02 i1="01" i2="X"><s0>002B17B</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Dystonie</s0></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Antagoniste dopamine</s0></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Pathologie expérimentale</s0></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Pathogénie</s0></fC03><fC03 i1="10" i2="X" l="FRE"><s0>Cartographie</s0></fC03><fC03 i1="12" i2="X" l="FRE"><s0>Densitométrie</s0></fC03><fC03 i1="14" i2="X" l="FRE"><s0>Autoradiographie</s0></fC03><fC03 i1="15" i2="X" l="FRE"><s0>Encéphale</s0></fC03><fC03 i1="18" i2="X" l="FRE"><s0>Exploration radioisotopique</s0></fC03><fC03 i1="22" i2="X" l="FRE"><s0>Système nerveux pathologie</s0></fC03><fC03 i1="23" i2="X" l="FRE"><s0>Singe</s0></fC03><fC03 i1="24" i2="X" l="FRE"><s0>Animal</s0></fC03><fC03 i1="25" i2="X" l="FRE"><s0>MPTP</s0><s4>INC</s4></fC03><fC03 i1="26" i2="X" l="FRE"><s0>Glucose(désoxy-2)</s0><s4>INC</s4></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Dystonia</s0></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Dopamine antagonist</s0></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Experimental disease</s0></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Pathogenesis</s0></fC03><fC03 i1="10" i2="X" l="ENG"><s0>Cartography</s0></fC03><fC03 i1="12" i2="X" l="ENG"><s0>Densitometry</s0></fC03><fC03 i1="14" i2="X" l="ENG"><s0>Autoradiography</s0></fC03><fC03 i1="15" i2="X" l="ENG"><s0>Brain</s0></fC03><fC03 i1="18" i2="X" l="ENG"><s0>Radionuclide study</s0></fC03><fC03 i1="22" i2="X" l="ENG"><s0>Nervous system diseases</s0></fC03><fC03 i1="23" i2="X" l="ENG"><s0>Monkey</s0></fC03><fC03 i1="24" i2="X" l="ENG"><s0>Animal</s0></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Distonía</s0></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Antagonista dopamina</s0></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Patología experimental</s0></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Patogenia</s0></fC03><fC03 i1="10" i2="X" l="SPA"><s0>Cartografía</s0></fC03><fC03 i1="12" i2="X" l="SPA"><s0>Densitometría</s0></fC03><fC03 i1="14" i2="X" l="SPA"><s0>Autorradiografía</s0></fC03><fC03 i1="15" i2="X" l="SPA"><s0>Encéfalo</s0></fC03><fC03 i1="18" i2="X" l="SPA"><s0>Exploración radioisotópica</s0></fC03><fC03 i1="22" i2="X" l="SPA"><s0>Sistema nervioso patología</s0></fC03><fC03 i1="23" i2="X" l="SPA"><s0>Mono</s0></fC03><fC03 i1="24" i2="X" l="SPA"><s0>Animal</s0></fC03><fC04 i1="01" i2="X"><s0>PU01!24,06</s0></fC04><fC07 i1="01" i2="X" l="FRE"><s0>Primates</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Primates</s0></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Mammalia</s0></fC07><fC07 i1="06" i2="X" l="ENG"><s0>Vertebrata</s0></fC07><fC07 i1="07" i2="X" l="SPA"><s0>Primates</s0></fC07><fC07 i1="08" i2="X" l="SPA"><s0>Mammalia</s0></fC07><fC07 i1="09" i2="X" l="SPA"><s0>Vertebrata</s0></fC07><fN21><s1>009</s1></fN21></pA></standard></inist><affiliations><list></list><tree><noCountry><name sortKey="Boyce, S" sort="Boyce, S" uniqKey="Boyce S" first="S." last="Boyce">S. Boyce</name><name sortKey="Clarke, C E" sort="Clarke, C E" uniqKey="Clarke C" first="C. E." last="Clarke">C. E. Clarke</name><name sortKey="Crossman, A R" sort="Crossman, A R" uniqKey="Crossman A" first="A. R." last="Crossman">A. R. Crossman</name><name sortKey="Luquin, R" sort="Luquin, R" uniqKey="Luquin R" first="R." last="Luquin">R. Luquin</name><name sortKey="Mitchell, I J" sort="Mitchell, I J" uniqKey="Mitchell I" first="I. J." last="Mitchell">I. J. Mitchell</name><name sortKey="Robertson, R G" sort="Robertson, R G" uniqKey="Robertson R" first="R. G." last="Robertson">R. G. Robertson</name><name sortKey="Sambrook, M A" sort="Sambrook, M A" uniqKey="Sambrook M" first="M. A." last="Sambrook">M. A. Sambrook</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003937 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 003937 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:90-0127385
|texte= Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia
}}
| This area was generated with Dilib version V0.6.23. |  |